Page last updated: 2024-08-23

paclitaxel and Hepatic Encephalopathy

paclitaxel has been researched along with Hepatic Encephalopathy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feenstra, J; Stricker, BH; Vermeer, RJ1
BarĂ³n, A; Bearman, SI; Cagnoni, PJ; DeBoom, T; Jones, RB; Matthes, S; Nieto, Y; Shpall, EJ1

Trials

1 trial(s) available for paclitaxel and Hepatic Encephalopathy

ArticleYear
Acute encephalopathy: a new toxicity associated with high-dose paclitaxel.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Neoplasms; Paclitaxel; Psychotropic Drugs

1999

Other Studies

1 other study(ies) available for paclitaxel and Hepatic Encephalopathy

ArticleYear
Fatal hepatic coma attributed to paclitaxel.
    Journal of the National Cancer Institute, 1997, Apr-16, Volume: 89, Issue:8

    Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Fatal Outcome; Female; Hepatic Encephalopathy; Humans; Middle Aged; Paclitaxel

1997